Table 2.
Antimicrobial susceptibility of selected five multidrug resistant Salmonella isolates according to CLSI (2012).
| Antibiotics |
Salmonella isolates |
||||
|---|---|---|---|---|---|
| S. Tm 7 | S. En 22 | S. Ty 49 | S. Tm 54 | S .Tm 57 | |
| Aminoglycosides | |||||
| Streptomycin (S) | R | S | R | R | R |
| Gentamycin (GN) | R | R | R | R | R |
| Amikacin (AK) | R | R | R | R | I |
| β-Lactams | |||||
| Ampicillin (AMP) | R | R | R | R | R |
| Amoxicillin/clavulanic acid (AMC) | R | R | R | R | R |
| Oxacillin (OX) | R | R | R | R | R |
| Cefotaxime (CTX) | R | R | I | R | R |
| Ceftazidine (CAZ) | R | R | S | R | S |
| Cefipime (FEP) | R | R | R | R | R |
| Quinolones and fluoroquinolones | |||||
| Ciprofloxacin (CIP) | R | R | R | R | R |
| Levofloxacin (LEV) | R | R | R | R | R |
| Ofloxacin (OFX) | R | R | R | R | R |
| Norfloxacin (NOR) | R | R | R | R | I |
| Nalidixic acid (NA) | R | R | R | R | R |
Susceptible, intermediate and resistant phenotypes, from CLSI breakpoints.